Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
-
Authors :
Magen O; From the Clalit Research Institute, Innovation Division (O.M., J.G.W., M.M.-A., R.D.B., N.D.), and the Tel-Aviv District, Community Division (R.V.), Clalit Health Services, and the Sackler Faculty of Medicine, Tel-Aviv University (D.D.), Tel Aviv, the Department of Internal Medicine D, Hasharon Hospital Rabin Medical Center, Petah Tikva (D.D.), and the School of Public Health, Faculty of Health Sciences (R.D.B.), and the Department of Software and Information Systems Engineering (N.D.), Ben Gurion University of the Negev, Be'er Sheva - all in Israel; and the Departments of Epidemiology and Biostatistics and CAUSALab (M.A.H.) and the Center for Communicable Disease Dynamics, Departments of Epidemiology and of Immunology and Infectious Diseases (M.L.), Harvard T.H. Chan School of Public Health, the Ivan and Francesca Berkowitz Family Living Laboratory Collaboration at Harvard Medical School and Clalit Research Institute (B.Y.R., R.D.B., N.D.), the Predictive Medicine Group, Computational Health Informatics Program, Boston Children's Hospital (B.Y.R.), and the Departments of Pediatrics (B.Y.R.) and Biomedical Informatics (B.Y.R., N.D.), Harvard Medical School - all in Boston.
Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/therapeutic use ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control SARS-CoV-2 variants
-
Source:
The New England journal of medicine [N Engl J Med] 2022 Apr 28; Vol. 386 (17), pp. 1603-1614. Date of Electronic Publication: 2022 Apr 13.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium:
Record details
-
Authors :
Zeng C; Center for Retrovirus Research, Ohio State University, Columbus, OH 43210, USA; Department of Veterinary Biosciences, Ohio State University, Columbus, OH 43210, USA.
Subjects: Immunization, Secondary*; 2019-nCoV Vaccine mRNA-1273/2019-nCoV Vaccine mRNA-1273/2019-nCoV Vaccine mRNA-1273/*immunology ; Antibodies, Neutralizing/Antibodies, Neutralizing/Antibodies, Neutralizing/*immunology COVID-19 breakthrough infectionsSARS-CoV-2 variants
-
Source:
Cancer cell [Cancer Cell] 2022 Feb 14; Vol. 40 (2), pp. 117-119. Date of Electronic Publication: 2021 Dec 30.Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN:
Record details
-
Authors :
Azzi L; Azienda Socio-Sanitaria Territoriale dei Sette Laghi, Department of Medicine and Surgery, University of Insubria, Varese, Italy. Electronic address: .; Dalla Gasperina D
Subjects: Immunization, Secondary*; Antibodies, Neutralizing/Antibodies, Neutralizing/Antibodies, Neutralizing/*immunology ; Antibodies, Viral/Antibodies, Viral/Antibodies, Viral/*immunology
-
Source:
EBioMedicine [EBioMedicine] 2022 Jan; Vol. 75, pp. 103788. Date of Electronic Publication: 2021 Dec 23.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:
Record details
-
Authors :
Bar-On YM; From the Department of Plant and Environmental Sciences, Weizmann Institute of Science, Rehovot (Y.M.B.-O., R.M.), Technion-Israel Institute of Technology, Haifa (Y.G.), the Department of Statistics and Data Science, Hebrew University of Jerusalem (M.M.), and Israel Ministry of Health (O.B., S.A.-P., N.A.), Jerusalem, the Biostatistical and Biomathematical Unit, Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, Ramat Gan (L.F., A.H.), and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv (L.F., A.H.) - all in Israel.; Goldberg Y
Subjects: BNT162 Vaccine* ; Immunization, Secondary* ; Patient Acuity*
-
Source:
The New England journal of medicine [N Engl J Med] 2021 Dec 23; Vol. 385 (26), pp. 2421-2430. Date of Electronic Publication: 2021 Dec 08.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium:
Record details
-
Authors :
Arbel R; From the Community Medical Services Division, Clalit Health Services, Tel Aviv (R.A., A.H., A.P., D.N., S.Y.), the Maximizing Health Outcomes Research Lab, Sapir College, Sderot (R.A.), and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beersheba (R.S., M.F.) - all in Israel.; Hammerman A
Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/immunology ; Immunization, Secondary*; COVID-19/COVID-19/COVID-19/*mortality
-
Source:
The New England journal of medicine [N Engl J Med] 2021 Dec 23; Vol. 385 (26), pp. 2413-2420. Date of Electronic Publication: 2021 Dec 08.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium:
Record details
